Kineta, Inc.

Dec 15, 2020

Kineta Announces First Participant Dosed in Phase 1 Clinical Trial of KCP506, A Novel Non-Opioid for the Treatment of Chronic Pain

Dec 09, 2020

Kineta Presents New Preclinical Data at ESMO Virtual Congress 2020 on its VISTA Antagonist Antibodies

Nov 12, 2020

Kineta Presents New Preclinical Data at the 2020 SITC Annual Meeting on its VISTA Antagonist Antibodies

Oct 20, 2020

Kineta Presents New Preclinical Data on its VISTA Antagonist Antibodies at the American Association for Cancer Research (AACR) Virtual Special Conference on Tumor Immunology and Immunotherapy

Oct 08, 2020

Kineta to Extend Research Collaboration with Genentech to Develop a Novel Non-Opioid

May 05, 2020

Kineta Closes Investment Round to Advance Early Preclinical Development of Immuno-oncology Programs

Apr 21, 2020

Kineta Announces Formation of New Immuno-oncology Focused Scientific Advisory Board